Want to listen to music with psychedelics? Researchers at Johns Hopkins University are seeking healthy individuals ages 21-75 to participate in a research study evaluating the role of music during psychedelic experiences. Apply at jhmi.co1.qualtrics.com/jfe/form/SV_...

Dr. Sandeep Nayak presented findings from our clinical trial of psilocybin for PTSD at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2026 in the Netherlands. Stay tuned for full results published soon!

Interested in experiencing psychedelics under professional supervision? We are seeking healthy adults between the ages 21-65 to participate in a new clinical trial looking at the effects of psilocybin and its interaction with other medications. Apply at jhmi.co1.qualtrics.com/jfe/form/SV_...

CPCR Assistant Professor, Dr. Brandon Weiss, interviews with CNBC regarding the executive order on accelerated psychedelic research. Weiss cautions that there are different risks associated with each psychedelic compound:

JHU PhD student Katherine Cheung and PhD Candidate Caleigh Propes, with CPCR Associate Professor Dr. David Yaden, evaluated comparison sets on the price of Oregon’s psilocybin services.

Drs. Fred Barrett and David Yaden have received a 2026 Johns Hopkins Nexus Award alongside fellow JHU scientists, educators, bioethicists, and economists to advance critical conversations around the future of psychedelic policy. hub.jhu.edu/2026/05/29/j...

Join us tomorrow, Wednesday May 27, for the Psychedelic Archives Project Guest Speaker Series! 🎤Dr. Timo Schmidt ( @Titoschmi ) 🗓 May 25, 2026 | ⏰ 4:30 PM EDT 🎟 Free to attend — sign up at the link below and in our bio!👇 jhubluejays.zoom.us/j/92622903856

Congratulations to Kristy Arthur on an outstanding showing at the Collaborative Perspectives on Addiction Annual Meeting!

This Memorial Day, we honor those who gave everything in service to this country and we hold space for those still carrying invisible wounds.

Check out this thoughtful interview with Dr. Bit Yaden and Josh Hardman at Psychedelic Alpha, discussing a collaborative educational project between Johns Hopkins, NYU, Penn, and Yale. psychedelicalpha.com/news/bit-yad...

CPCR Medical Director, Dr. Sandeep Nayak, interviews with Forbes on the psychedelic compound, methylone, being explored in FDA-approved research for post-traumatic stress disorder: www.forbes.com/health/mind/...

CPCR Medical Director, Dr. Sandeep Nayak, will be speaking at the Interdisciplinary Conference on Psychedelic Research in the Netherlands on June 4-6!

Rodrigo Guerra, biomedical engineering PhD candidate with the CPCR, was recognized as 2026 Graduate Student Employee of the Year in April! This award is reserved for those who go above and beyond in their roles among thousands of undergrad and graduate student employees at Johns Hopkins University.

We are seeking individuals to participate in a research study on the effects of psychedelics on addictive behaviors including problems with gambling, video gaming, internet/social media, pornography and other sexual behaviors, and shopping and buying behaviors. hopkinspsychedelic.org/addictionsur...

Join us Wednesday, May 6 at 4:30pm ET for the Psychedelic Archives Project guest speaker series, featuring Dr. Erika Dyck, who is presenting "Psychedelics, Archives, and New Histories: how the psychedelic renaissance can change history." Join on this Zoom link: jhubluejays.zoom.us/j/92622903856

CPCR Medical Director, Dr. Sandeep Nayak, addresses current state of ibogaine research in interview with @sciam.bsky.social: “I firmly believe it should be studied and may be a very useful treatment, but the science for ibogaine is in a far more preliminary state than that of, say, psilocybin.”

New paper: Classic psychedelic and cannabis use among U.S. cancer survivors aged >= 50 years: nationally representative estimates by cancer type/site

Interested in becoming a psychedelic therapist? We’re seeking a full-time therapist to join our team and support innovative clinical trials exploring the therapeutic potential of psychedelics. Learn more and apply here: hiring.jhu.edu/careers/job/...

CPCR Associate Center Director, Albert Garcia-Romeu, quoted in The Guardian on psilocybin, state or FDA approval: there is “limited data to support using psilocybin to treat PTSD, and there could be unknown risks...”

CPCR Assistant Professor, Dr. Brandon Weiss, joins Disabled American Veterans for an interview exploring the current research on psychedelic treatments for Veteran mental health conditions like PTSD youtu.be/iKlLOn6XHHY?...

Psychedelic session facilitators play an important role in supporting participants before, during, and after psychedelic administration sessions. CPCR researchers and collaborators analyzed the largest dataset of its kind, featuring 20+ years of psilocybin trials from Johns Hopkins.

How do psychedelics alter brain activity? 🍄✨ A landmark study published this week in @NatureMedicine by CPCR researchers @FredBarrettPhD, @winstonian3 and a global team of collaborators analyzes the largest human psychedelic fMRI dataset to-date.

Join us Wednesday for the Psychedelic Archives Project Guest Speaker Series! 🎤 Jeffrey Breau, MDiv. 🗓 April 15, 2026 | ⏰ 4:30 PM EDT 🎟 Free to attend — sign up at the link below and in our bio!👇 jhubluejays.zoom.us/j/92622903856

Have you had separate experiences with psychedelics and cannabis? If so, take our survey! tinyurl.com/psyches-cann... Your responses help us understand these compounds better, so that we can continue to expand the science of psychedelics and knowledge about their risks and benefits.

Thanks Dr. Chuck Nichols for presenting at the CPCR journal club! Watch Dr. Nichols' full presentation on using preclinical models to investigate the therapeutic potential of psychedelics 🔗👇

CPCR Faculty David Yaden was quoted in the New Yorker on one of the more interesting scientific questions in the field of psychedelics - what role (if any) the psychedelic experience has in their persisting effects www.newyorker.com/culture/anna...

It's not too late to sign up for our upcoming continuing education course on March 26th! Learn from our expert faculty and earn up to 6.5 CE/CMEs

Wondering what clinicians should know about psychedelic-assisted treatments? tinyurl.com/hopkinscme Join our upcoming CME/CE course designed to help clinicians engage with patients, understand new research, and prepare for the future of psychedelic-assisted care.

New findings from a pilot randomized trial of psilocybin for smoking cessation are now published in JAMA Open Network — this is one of the largest controlled trials of psilocybin for substance use disorder, with promising results! jamanetwork.com/journals/jam...

Thrilled to announce our new CME course on psychedelic medicine, taught by CPCR faculty! Designed for physicians, advanced practice providers, mental health clinicians, & anyone interested in psychedelic medicine. ✔ Up to 6.5 CME/CE credits 📅 March 27, 2026 | Live Online 🔗 tinyurl.com/hopkinscme

Ready for a weekend of science at the International Society for Research on Psychedelics (ISRP)

New pilot study from Johns Hopkins finds psilocybin-assisted treatment was associated with significant and sustained benefits in post-treatment Lyme disease, including improved mood, fatigue, sleep, pain, and quality of life for up to 6 months. More research is needed to confirm. Read more below 👇

Huge congratulations to Dr. Albert Garica-Romeu who was recently named a Frontiers of Science Fellow by the National Academy of Sciences! tinyurl.com/2cbkt93c

A new review in Psychiatric Times examines adverse event data for psilocybin, MDMA, ketamine, and ibogaine, finding meaningful differences in risk and inconsistent reporting. Clear compound-level distinctions are crucial as access expands. www.psychiatrictimes.com/view/adverse...

Dr. Fred Barrett co-authored a new paper on the challenges of running rigorous psychedelic clinical trials — from expectancy effects to blinding. As therapies near FDA approval, strong science is essential. Read more: journals.sagepub.com/doi/10.1177/...

🔬 We are hiring a Research Data Analyst. Learn more and apply: hiring.jhu.edu/careers?quer...

Dr. Brandon Weiss explores how MDMA and psilocybin may help rewire fear patterns in PTSD, including a new PAMVET trial on combining the two. Learn more below.https://www.livescience.com/health/mind/psychedelics-may-rewire-the-brain-to-treat-ptsd-scientists-are-finally-beginning-to-understand-how

CPCR Medical Director Dr. Sandeep Nayak weighs in on where psilocybin therapy for PTSD is headed – from policy shifts to clinical progress and what it means for the future of care www.lucid.news/legislation-...

We're excited to unveil our redesigned CPCR website! Whether you're interested in participating in cutting-edge clinical trials, exploring our research publications, or accessing information about our integration clinic and online courses. Check it out! hopkinspsychedelic.org

Can psilocybin assisted therapy reduce opioid use and improve quality of life? We are seeking people near Baltimore, Maryland with Opioid Use Disorder to participate in a trial to see if psilocybin can reduce opioid use and improve quality of life. jhmi.co1.qualtrics.com/jfe/form/SV_...

The Psychedelic Archives Project Guest Speaker Series continues this Wednesday with Dr. Nicolas Langlitz. 🗓 February 11th, 2026 | ⏰ 4:30 PM EST 🎟 Attendance is free — registration link below 👇 jhubluejays.zoom.us/j/92622903856

Ongoing debate about psychological support versus psychotherapy in psychedelic trials often stems from vague definitions. Clarifying these constructs is essential for rigorous study of safety and efficacy.

Join us Wednesday for the Psychedelic Archives Project Guest Speaker Series! 🎤 Dr. Larissa Carneiro 🗓 January 28, 2026 | ⏰ 4:30 PM EST 🎟 Free to attend — sign up at the link below! 👇 jhubluejays.zoom.us/j/92622903856

Have you had separate experiences with psychedelics and cannabis? Take our short survey to help expand research on their effects: tinyurl.com/psyches-cann...

Curious about psychedelics beyond the hype? Our new Coursera course, Psychedelic Science and Medicine, offers clear, evidence-based insight into how they work and who may benefit. Ideal for clinicians, students, researchers, and curious learners. Enroll below 👇

SEEKING HEALTHY VOLUNTEERS FOR A PSYCHEDELIC STUDY 🔗 tinyurl.com/34jnz3d5 📞 410-550-2253 ✉️ [email protected]

Dr. Brandon Weiss spoke on psychedelic therapy at the AcademyHealth conference for VA clinicians. Thanks to Dr. Matthew Boehm and fellow panelists. CPCR is focused on implementing these therapies in healthcare.

Join us- the Psychedelic Archives Project guest speaker series is Dr. Catherine Freddo, presenting on today Jan 7, 2025 at 4:30pm EST. Join for free at the link below! 👇 jhubluejays.zoom.us/j/92622903856

Want to help researchers better understand how psychedelic experiences impact mood and cognitive functioning? Please take part in our anonymous survey! jhmi.co1.qualtrics.com/jfe/form/SV_...

Next up in the Psychedelic Archives Project guest speaker series is Dr. Catherine Freddo, presenting on Jan 7, 2025 at 4:30pm EST. Join for free at the link below! 👇 jhubluejays.zoom.us/j/92622903856